Navigation Links
SIGMA-ALDRICH INVESTOR ALERT: Levi & Korsinsky, LLP Investigates the Board of Directors of Sigma-Aldrich Corporation In Connection with the Sale of the Company to Merck -- SIAL
Date:9/22/2014

NEW YORK, Sept. 22, 2014 /PRNewswire/ -- Levi & Korsinsky is investigating the Board of Directors of Sigma-Aldrich Corporation ("Sigma-Aldrich" or "the Company") (NasdaqGS: SIAL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to German drug company Merck.

Click here to learn more about the investigation: http://zlkdocs.com/SIAL-Info-Request-Form_ma-2199, or call: 877-363-5972. There is no cost or obligation to you.

Under the terms of the transaction, Sigma-Aldrich shareholders will receive $140 for each share of Sigma-Aldrich common stock they own. The transaction has a total approximate value of $17 billion. The investigation concerns whether the Board of Sigma-Aldrich breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Merck is underpaying for Sigma-Aldrich shares.

If you own Sigma-Aldrich common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlkdocs.com/SIAL-Info-Request-Form_ma-2199.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com

Logo - http://photos.prnewswire.com/prnh/20120409/MM84375LOGO 


'/>"/>
SOURCE Levi & Korsinsky, LLP
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
2. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
3. Sigma-Aldrich Corporation To Present At Upcoming Investor Conferences
4. Sigma-Aldrich Enhances Customer Focus in China - Unveils Dynamic New Website and Expands Product Offering Through Vetec Brand
5. Sigma-Aldrich (NASDAQ: SIAL) Declares $0.20 Quarterly Dividend
6. Sigma-Aldrich Aligns Into Three New Market-Focused Business Units
7. Sigma-Aldrich Reports Record Full Year 2012 Results. Reports Q4 2012 Diluted EPS Of $0.96. Q4 2012 Sales Increased 7%. Full Year 2012 Adjusted Diluted EPS Was $3.85. Expects Full Year 2013 Adjusted Diluted EPS To Increase To $4.10 - $4.20.
8. Sigma-Aldrich Corporations Sigma Life Science Business to Distribute Worldwide Olink Biosciences Protein Interaction Analysis Technology
9. Sigma-Aldrich Announces Q1 2013 Earnings Conference Call
10. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2013 Sales And EPS Of $675 Million And $1.01, Respectively, Both Record Quarterly Highs. Reaffirms Full Year 2013 Diluted Adjusted EPS Outlook Of $4.10 To $4.20.
11. Sigma-Aldrich Corporation Declares $0.215 Per Share Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2020)... ... 2020 , ... NeoTract, a wholly owned subsidiary of Teleflex ... announced that Jayant Uberoi, MD, Chesapeake Urology in Baltimore MD, has been designated ... achieved a high level of training and experience with the UroLift® System and ...
(Date:2/19/2020)... ... ... Aspire Regenerative, a leader in offering therapies that restore healthy tissues in the ... on March 1, 2020. It will take place from 10:30 a.m. to 1:30 p.m. ... event, physicians and pharmacists will lead an informative and insightful discussion on weight loss. ...
(Date:2/19/2020)... ... February 19, 2020 , ... The Team Type 1 Foundation, ... medicine for everyone affected by diabetes, announced a partnership with VeloCity, a fundraising ride ... third annual VeloCity event takes place on May 2nd and begins on the Mercedes-Benz ...
Breaking Medicine Technology:
(Date:2/23/2020)... ... February 22, 2020 , ... One of the stars of ... is the host of the informational program “Behind The Scenes.” “Behind The Scenes” ... the country. A soon to be aired episode will interview industry professionals about ...
(Date:2/21/2020)... , ... February 21, 2020 , ... Representatives with Bay-Bay Water today announced ... launch of Bay-Bay Water’s new company logo as part of the ongoing evolution of our ... at a time when the company is expanding its national reach. , “We have refreshed ...
(Date:2/21/2020)... ... February 21, 2020 , ... Isagenix International , ... its third and final round of Canada finalists for its annual total-body transformation ... of Markdale, Ontario; Taiya Farrell of Winnipeg, Manitoba; Véronique Collin of Orleans, Ontario; ...
(Date:2/20/2020)... ... February 20, 2020 , ... TMQuotes ... release with next generation API integration functionality which enables agents to take more ... in 2017, TMQuotes was the first white label software-as-a-service (SaaS) to give insurance ...
(Date:2/19/2020)... ... February 19, 2020 , ... ... While he is most known for his acting abilities demonstrated in blockbuster hits ... educational show “Behind The Scenes” with Laurence Fishburne. “Behind The Scenes” features a ...
Breaking Medicine News(10 mins):